Trials / Recruiting
RecruitingNCT06314477
Effect of CPAP Treatment in Patients With Severe Uncontrolled Asthma: The ASTHMA-SLEEP Trial
Effect of CPAP Treatment on Asthma Control in Patients With Severe Uncontrolled Asthma and Obstructive Sleep Apnea: The ASTHMA-SLEEP Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 138 (estimated)
- Sponsor
- Hospital Clinic of Barcelona · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate the impact of CPAP treatment on asthma control in patients with severe uncontrolled asthma and obstructive sleep apnea (OSA)
Detailed description
Background: The prevalence of obstructive sleep apnea (OSA) is high in patients with severe uncontrolled asthma and can worsen asthma control. Previous observational studies demonstrated that CPAP treatment could improve control in patients with mild-moderate asthma. Nevertheless, there are no studies in patients with severe uncontrolled asthma. Primary objective: To evaluate the impact of CPAP treatment on asthma control in patients with severe uncontrolled asthma and AOS. Methodology: Multicenter, prospective, randomized, controlled clinical trial with parallel groups in subjects with severe uncontrolled asthma who are older than 18 years and without sleepiness (Epworth sleepiness scale score ≤10). All included subjects will undergo conventional polysomnography and those with an apnea-hypopnea index (AHI) ≥15/hour will be randomized in a 1:1 ratio to receive conservative treatment or conservative treatment plus CPAP. Monitoring will be carried out during12 months. Patients will be evaluated at inclusion, at 1 month, 6 and 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CPAP treatment | Subjects allocated to this arm will receive continuous positive airway pressure (CPAP) |
| OTHER | Hygienic and dietary advice | Subjects allocated to this arm will receive hygienic and dietary counselling |
Timeline
- Start date
- 2023-12-27
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2024-03-18
- Last updated
- 2025-12-11
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06314477. Inclusion in this directory is not an endorsement.